Mark Matson
Impact in
- Gastroenterology top 5%
- Celiac Disease Research and Management
- Surgery top 10%
- Lipoproteins and Cardiovascular Health
Papers in
-
- HIV/AIDS drug development and treatment 3
-
- Hepatitis C virus research 2
- Co-authors
- Adam J. Shaywitz (2 shared papers)Brian P. Smith (2 shared papers)Maurice G. Emery (2 shared papers)Blaire P. Cooke (2 shared papers)Bing Gao (2 shared papers)Scott M. Wasserman (2 shared papers)John P. Gibbs (2 shared papers)Clapton S. Dias (2 shared papers)
- Journals
- Antiviral Research (2 papers)Current Medical Research and Opinion (2 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Hepatology (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Mark Matson
18 papers receiving 555 citations
Peers
Comparison fields: 5 of 64
- Gastroenterology 59
- Surgery 206
- Nephrology 36
- Immunology 69
- Endocrine and Autonomic Systems 14
Countries citing papers authored by Mark Matson
This map shows the geographic impact of Mark Matson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Matson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Matson more than expected).
Fields of papers citing papers by Mark Matson
This network shows the impact of papers produced by Mark Matson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Matson. The network helps show where Mark Matson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Matson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 214 | |
| 2 | 2021 | 145 | |
| 3 | 2011 | 41 | |
| 4 | 2011 | 35 | |
| 5 | 1988 | 28 | |
| 6 | 2016 | 24 | |
| 7 | 2019 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2014 | 12 | |
| 10 | 2011 | 11 | |
| 11 | 2014 | 11 | |
| 12 | 2011 | 9 | |
| 13 | 1987 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2024 | 6 | |
| 16 | 2012 | 3 | |
| 17 | 2009 | 2 | |
| 18 | 2009 | 1 |
About Mark Matson
Mark Matson is a scholar working on Infectious Diseases, Hepatology, Nephrology, Statistics and Probability and Rheumatology, having authored 18 papers that have together received 582 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (3 papers), Hepatitis C virus research (2 papers), Dialysis and Renal Disease Management (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Statistical Methods in Clinical Trials (2 papers), Herpesvirus Infections and Treatments (2 papers) and Multiple Sclerosis Research Studies (2 papers). The work is most often cited by research in Gastroenterology (59 citations), Surgery (206 citations), Nephrology (36 citations), Immunology (69 citations) and Endocrine and Autonomic Systems (14 citations). Mark Matson has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Adam J. Shaywitz, Brian P. Smith, Maurice G. Emery, Blaire P. Cooke, Bing Gao, Scott M. Wasserman, John P. Gibbs, Clapton S. Dias, Karen Vossen Smirnakis and Marc W. Retter. Their work appears in journals such as Antiviral Research, Current Medical Research and Opinion, The Journal of Clinical Pharmacology, Journal of Hepatology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.